RNACure
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.rnacure.comRevenue
<$5 MillionIndustry
About RNACure
RNACure BioPharma is an innovative drug company established in April 2019, specializing in mRNA technology and product development. The company has developed a comprehensive mRNA drug technology platform that includes target discovery, sequence design, delivery systems, and manufacturing processes. RNACure focuses on creating mRNA vaccines and therapies for severe diseases, aiming to advance clinical translation and establish a global leadership position in mRNA drug research and development. Their core team consists of leading scientists with extensive experience in mRNA research from prestigious institutions.Explore more
RNACure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to RNACure
Compare insights from companies similar to RNACure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RNACure Tech Stack
A closer look at the technologies used by RNACure
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RNACure
Sign Up For FreeTo access detailed company insights
RNACure BioPharma is an innovative drug company established in April 2019, specializing in mRNA technology and product development. The company has developed a comprehensive mRNA drug technology platform that includes target discovery, sequence design, delivery systems, and manufacturing processes. RNACure focuses on creating mRNA vaccines and ther... Read More
